Evaluation of deacetylase inhibition in metaplastic breast carcinoma using multiple derivations of preclinical models of a new patient-derived tumor
T. Chang, M. D. Matossian, S. Elliot, H. E. Burks, R. A. Sabol, A. D. Ucar, H. Wathieu, J. Zabaleta, L. D. Valle, S. Gill, E. Martin, A. I. Riker, L. Miele, B. A. Bunnell, M. E. Burow, B. M. Collins-Burow
This study evaluates deacetylase inhibitors in metaplastic breast carcinoma using multiple preclinical models, finding they reduce metastasis and synergize with chemotherapy.
bioRxiv · Nov 29, 2019Cancer Biology